Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Damien Eggenspieler

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Advanced Materials (Deerfield Beach, Fla.)|August 24, 2012
Deterministic order in surface micro-topologies through sequential wrinklingJie Yin, Jose Luis Yagüe, Damien Eggenspieler, et al.
Nature Medicine|October 9, 2023
First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMDLaurent Servais, Damien Eggenspieler, Margaux Poleur, et al.
Journal of Neuromuscular Diseases|April 19, 2024
Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular DystrophyMichael Rabbia, Maitea Guridi Ormazabal, Hannah Staunton, et al.
Children (Basel, Switzerland)|September 28, 2023
Qualitative Insights into Key Angelman Syndrome Motor Related Concepts Reported by Caregivers-A Thematic Analysis of Semi-Structured InterviewsMiranda Rogers, Stéphane Motola, Yacine Bechichi, et al.
Digital Biomarkers|November 1, 2021
First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular DiseasesLaurent Servais, Eric Camino, Aude Clement, et al.
Orphanet Journal of Rare Diseases|July 20, 2021
Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environmentMargaux Poleur, Ana Ulinici, Aurore Daron, et al.
NPJ Digital Medicine|March 29, 2023
Evolving regulatory perspectives on digital health technologies for medicinal product developmentSeya Colloud, Thomas Metcalfe, Scott Askin, et al.
Eclinicalmedicine|March 20, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosisMargaux Poleur, Barbara Willekens, Bertrand Degos, et al.
Journal of Neuromuscular Diseases|April 12, 2021
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019Jonathan Pini, Gabriele Siciliano, Pauline Lahaut, et al.
Scientific Reports|November 29, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpointLaurent Servais, Paul Strijbos, Margaux Poleur, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Advanced Materials (Deerfield Beach, Fla.)|August 24, 2012
Deterministic order in surface micro-topologies through sequential wrinklingJie Yin, Jose Luis Yagüe, Damien Eggenspieler, et al.
Nature Medicine|October 9, 2023
First regulatory qualification of a digital primary endpoint to measure treatment efficacy in DMDLaurent Servais, Damien Eggenspieler, Margaux Poleur, et al.
Journal of Neuromuscular Diseases|April 19, 2024
Stride Velocity 95th Centile Detects Decline in Ambulatory Function Over Shorter Intervals than the 6-Minute Walk Test or North Star Ambulatory Assessment in Duchenne Muscular DystrophyMichael Rabbia, Maitea Guridi Ormazabal, Hannah Staunton, et al.
Children (Basel, Switzerland)|September 28, 2023
Qualitative Insights into Key Angelman Syndrome Motor Related Concepts Reported by Caregivers-A Thematic Analysis of Semi-Structured InterviewsMiranda Rogers, Stéphane Motola, Yacine Bechichi, et al.
Digital Biomarkers|November 1, 2021
First Regulatory Qualification of a Novel Digital Endpoint in Duchenne Muscular Dystrophy: A Multi-Stakeholder Perspective on the Impact for Patients and for Drug Development in Neuromuscular DiseasesLaurent Servais, Eric Camino, Aude Clement, et al.
Orphanet Journal of Rare Diseases|July 20, 2021
Normative data on spontaneous stride velocity, stride length, and walking activity in a non-controlled environmentMargaux Poleur, Ana Ulinici, Aurore Daron, et al.
NPJ Digital Medicine|March 29, 2023
Evolving regulatory perspectives on digital health technologies for medicinal product developmentSeya Colloud, Thomas Metcalfe, Scott Askin, et al.
Eclinicalmedicine|March 20, 2026
Stride-level measurement of gait as an early sensitive marker of disability progression in ambulatory patients with multiple sclerosisMargaux Poleur, Barbara Willekens, Bertrand Degos, et al.
Journal of Neuromuscular Diseases|April 12, 2021
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 1st eNMD Congress: Nice, France, March 22-23, 2019Jonathan Pini, Gabriele Siciliano, Pauline Lahaut, et al.
Scientific Reports|November 29, 2024
Evidentiary basis of the first regulatory qualification of a digital primary efficacy endpointLaurent Servais, Paul Strijbos, Margaux Poleur, et al.
Pageof 2